| Contents |
Sensitive methods for detection of SARS-CoV-2 RNA / Xi Chen and Simin Xia -- The seasonal behaviour of COVID-19 and its galectin-like culprit of the viral spike / Kelsey Caetano-Anollés, Nicolas Hernandez, Fizza Mughal, Tre Tomaszewski, and Gustavo Caetano-Anollés -- Current molecular diagnostics assays for SARS-CoV-2 and emerging variants / Jonathan M. Banks, Kristelle Capistrano, Pari Thakkar, Hemangi Ranade, Vaidik Soni, Manali Datta, and Afsar R. Naqvi -- CRISPR use in diagnosis and therapy for COVID-19 / Pallavi Deol, Aashwina Madhwal, Gaurav Sharma, Rahul Kaushik, and Yashpal Singh Malik -- Recent and advanced nano-technological strategies for COVID-19 vaccine development / Chinekwu Sherridan Nwagwu, Chinenye Nnenna Ugwu, John Dike Nwabueze Ogbonna, Adaeze Linda Onugwu, Chinazom Precious Agbo, Adaeze Chidiebere Echezona, Ezinwanne Nneoma Ezeibe, Samuel Uzondu, Frankline Chimaobi Kenechukwu, Paul Achile Akpa, Mumuni Audu Momoh, Petra Obioma Nnamani, Clemence Tarirai, Kenneth Chibuzor Ofokansi, and Anthony Amaechi Attama -- A review of hypersensitivity methods to detect immune responses to SARS-CoV-2 / Fernando Díaz-Espada, Victor Matheu, and Yvelise Barrios -- Hesitancy to get vaccinated against COVID-19 and how it might be overcome / Charles S. Pavia -- The emergence of SARS-CoV-2 variants of concern in Australia by haplotype coalescence reveals a continental link to COVID-19 seasonality / Tre Tomaszewski, Volker Gurtler, Kelsey Caetano-Anollés, and Gustavo Caetano-Annollés -- COVID-19 vaccines for high risk and immunocompromised patients / Charles S. Pavia and Maria M. Plummer. |
